Adalimumab maintains remission for up to 4 years in patients with ulcerative colitis

被引：0
|
作者：
Colombel, J. -F. [1 ]
Sandborn, W. J. [2 ]
Ghosh, S. [3 ]
Wolf, D. [4 ]
Panaccione, R. [3 ]
Feagan, B. [5 ]
Reinisch, W. [6 ]
Robinson, A. M. [7 ]
Lazar, A. [8 ]
Kron, M. [8 ]
Huang, B. [7 ]
Thakkar, R. B. [7 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
[2] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calgary, Dept Med, Calgary, AB, Canada
[4] Atlanta Gastroenterol Associates, Atlanta, GA USA
[5] Robarts Res Inst, London, ON N6A 5C1, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] AbbVie Inc, GPRD, N Chicago, IL USA
[8] AbbVie Deutschland GmbH & Co KG, GPRD, Ludwigshafen, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60691-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P571
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [1] Adalimumab Maintains Remission for Up to 4 Years in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Ghosh, Subrata
    Wolf, Douglas C.
    Panaccione, Remo
    Feagan, Brian G.
    Reinisch, Walter
    Robinson, Anne
    Lazar, Andreas
    Kron, Martina
    Huang, Bidan
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S589 - S590
  • [2] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal B.
    [J]. GASTROENTEROLOGY, 2012, 142 (02) : 257 - +
  • [3] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Warner, Ben
    Harris, Adam W.
    [J]. GASTROENTEROLOGY, 2012, 143 (01) : E42 - E42
  • [4] Adalimumab promotes clinical remission in patients with ulcerative colitis
    [J]. Nature Reviews Gastroenterology & Hepatology, 2012, 9 (1) : 6 - 6
  • [5] Filgotinib Induces and Maintains Ulcerative Colitis Remission
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (04): : 299 - 299
  • [6] Response and Remission Rates With up to 3 Years of Vedolizumab Treatment in Patients with Ulcerative Colitis
    Loftus, Edward V.
    Colombel, Jean-Frederic
    Previtali, Alessandro
    Smyth, Michael D.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S805 - S805
  • [7] Response and remission rates with up to 3 years of vedolizumab treatment in patients with ulcerative colitis
    Loftus, E. V., Jr.
    Colombel, J. -F.
    Previtali, A.
    Smyth, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S58 - S59
  • [8] Adalimumab in patients with ulcerative colitis
    Balatsos, V.
    Anastasiou, Th.
    Karoumpalis, I.
    Katselis, I.
    Vagia, A.
    Skandalis, N.
    [J]. ANNALS OF GASTROENTEROLOGY, 2010, 23 (01): : 64 - 66
  • [9] Histological Remission in Ulcerative Colitis in Deep Remission under Treatment with Adalimumab
    Tursi, Antonio
    Nenna, Rosanna
    Musci, Giovanni
    Elisei, Walter
    Picchio, Marcello
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2021, 30 (01) : 55 - 58
  • [10] Durable Clinical Remission and Response in Adalimumab-Treated Patients with Ulcerative Colitis
    Panaccione, R.
    Colombel, J. -F.
    Sandborn, W. J.
    Reinisch, W.
    D'Haens, G.
    Hommes, D.
    Ghosh, S.
    Pappalardo, B.
    Petersson, J.
    Robinson, A. M.
    Lazar, A.
    Zhou, Q.
    Thakkar, R. B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S256 - S257
12345